News | December 28, 2025
Briefs: CuraTeQ Biologics, Sigachi Industries and Natural Capsules
CuraTeQ Biologics and BioFactura USA to terminate agreement mutually
CuraTeQ Biologics and BioFactura USA to terminate agreement mutually
Healthcare and insurance are not parallel systems; they are interdependent pillars of patient trust
India plays a critical role in Bristol Myers Squibb’s global strategy
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
This approval confirms the facility's compliance with FDA quality standards and regulatory requirements
LANXESS Biosecurity Solutions aims to deliver “advanced disinfection and hygiene solutions to support Indian farmers in maintaining healthier and safer farm environments
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
The upcoming facility marks a strategic milestone in SOUKYA’s mission to make evidence-based holistic healthcare
From material selection to cooling tower management, every small decision affects long-term equipment reliability
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
Subscribe To Our Newsletter & Stay Updated
